News | November 03, 2023
Dabur India posts Q2 FY24 consolidated PAT at Rs. 515.05 Cr
The company has posted net profit of Rs.978.93 crores for the 6 months period ended September 30, 2023
The company has posted net profit of Rs.978.93 crores for the 6 months period ended September 30, 2023
Lyka Labs has reported total income of Rs. 28.23 crores during the period ended September 30, 2023
Morepen Laboratories has reported total income of Rs. 425 crores during the quarter ended September 30, 2023
Lincoln Pharmaceuticals has reported total income of Rs. 164.68 crores during the period ended September 30, 2023
Dr. Lal Path Labs has reported total income of Rs. 619.4 crores during the period ended September 30, 2023
The company has posted net profit of Rs.115.08 crores for half year ended September 30, 202
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
Sun Pharmaceutical Industries has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
The inspection of the facility conducted from August 7 to August 11, 2023
Subscribe To Our Newsletter & Stay Updated
